McKesson Ventures
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

McKesson Ventures Expands Portfolio Development Team and Invests in Market Research

by McKesson Ventures | Jan 7, 2021 | Press Releases

McKesson Ventures has added Lizzie Lee as its newest team member. She joins the firm as senior director, leading its portfolio development and market research efforts. With a decade of healthcare experience, Lee is well-positioned to help McKesson Ventures’ portfolio...

Michelle Snyder, Digital Health Veteran, Joins McKesson Ventures

by McKesson Ventures | Dec 1, 2020 | Press Releases

McKesson Ventures has hired Michelle Snyder as its newest investment partner. Snyder, a mobile health pioneer, is known for her leadership and guidance in building Epocrates, one of the healthcare industry’s first successful mobile health companies. She brings more...

McKesson Ventures Grows Leadership Team with New Partner Promotions

by McKesson Ventures | Sep 16, 2020 | Press Releases

McKesson Ventures has expanded its leadership team, promoting Jennifer Carter and Carrie Hurwitz Williams to partners in the organization. Their promotions reflect McKesson Ventures’ commitment to an apprentice model of mentoring and promoting from within. Carter...

McKesson Appoints Tom Rodgers to Executive Vice President & Chief of Strategy and Business Development Officer

by McKesson Ventures | Jun 5, 2020 | Press Releases

McKesson Corporation announced that Tom Rodgers has been appointed executive vice president and chief strategy and business development officer, effective June 5, 2020. In his new role, Rodgers will also become a member of the company’s Executive Operating Team....
Real-World Evidence Should Be Part of Clinical Trials in Oncology

Real-World Evidence Should Be Part of Clinical Trials in Oncology

by McKesson Ventures | Apr 6, 2020 | Media Coverage

McKesson’s Sarah Alwardt, Ph.D, recently wrote in OncLive about the importance of real-world evidence (RWE) in the field of cancer treatment research. Fewer than 5 percent of adults with cancer enroll in clinical trials, but sufficient enrollment is necessary in order...
Page 4 of 8« First«...23456...»Last »

Recent Posts

  • CoverMyMeds Announces Acquisition of Companies RxLightning and FastAuth
  • Komodo Health Partners With Nasdaq to Deliver First Integrated Healthcare-Specialized Data Insights to the Financial Services Industry
  • Atropos Health Expands Oncology MultiModal Network in the Atropos Evidence Network with Addition of Ontada
  • Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care
  • Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

Contact Us

Cookie Settings

In the News

World’s Best Digital Health Companies 2024

SSM Health partners with Inbound Health to offer in-home advanced care to patients

CancerIQ CEO Feyi Ayodele Named to Modern Healthcare’s 2024 Innovators List

Aster Insights Announces Research Partnership with FDA to Study the Effects of Patient Demographics on Diagnostic Indicators Used for Checkpoint Inhibitor Therapy

©2025 McKesson Ventures | Privacy Notice | Disclaimer
  • Follow
  • Follow